In patients with follicular lymphoma, delayed-onset neutropenia induced by anti-CD20 monoclonal antibodies frequently occurs during maintenance therapy and is preferentially associated with obinutuzumab

The prevalence of anti-CD20 monoclonal antibody (MoAb)-associated delayed-onset neutropenia (DON) varies between 8 and 27%. Despite the wide use of MoAbs as maintenance in follicular lymphoma (FL), data regarding DON occurrence and clinical consequences are limited. This study assessed DON prevalenc...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Annals of hematology 2024-12, Vol.103 (12), p.5861-5870
Hauptverfasser:	Fadaos, Nashwa, Dor, Yossi Ben, Azoulay, Tehila, Leiba, Ronit, Sharon-Horesh, Nurit, Levi, Tsofia, Horowitz, Netanel A., Tzoran, Inna, Lavi, Noa, Beyar-Katz, Ofrat, Dann, Eldad J., Zuckerman, Tsila, Ringelstein-Harlev, Shimrit
Format:	Artikel
Sprache:	eng
Schlagworte:	Hematology Immunotherapy Lymphoma Medicine Medicine & Public Health Monoclonal antibodies Neutropenia Oncology Targeted cancer therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!